XML 22 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows
 12 Months Ended
Jun. 30, 2023
USD ($)
Jun. 30, 2022
USD ($)
Jun. 30, 2021
USD ($)
Operating activities:      
Net income $ 93,358,000 $ 310,991,000 $ 69,593,000
Loss (income) from discontinued operations 8,394,000 (346,946,000) (6,145,000)
Income (loss) from continuing operations 101,752,000 (35,955,000) 63,448,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 14,299,000 22,611,000 12,824,000
Amortization and impairments to operating lease assets 48,470,000 44,748,000 50,651,000
Depreciation 41,575,000 44,574,000 33,888,000
Amortization of intangible assets 61,239,000 97,274,000 0
Amortization and write-off of debt discount and issuance costs 9,129,000 42,654,000 2,657,000
Reclassification adjustment from other comprehensive income 0 0 (126,000)
Provision for bad debts 32,999,000 27,141,000 11,023,000
Deferred income taxes (5,087,000) (544,000) 62,000
Loss on disposals, accelerated depreciation, and impairments to property and equipment 3,999,000 3,501,000 1,912,000
Gain on extinguishment of debt (71,000) (2,072,000) 0
Loss (gain) on investments 3,689,000 3,271,000 (2,638,000)
Gain on sale of assets (13,317,000) 0 0
Changes in assets and liabilities:      
Accounts receivable (37,614,000) (29,881,000) 15,443,000
Prepaid expenses and other current assets 9,324,000 (2,827,000) (17,969,000)
Accounts payable 21,666,000 (15,724,000) 5,666,000
Accrued payroll and benefits (15,683,000) (12,118,000) 12,552,000
Accrued liabilities 241,000 (16,305,000) 29,312,000
Deferred revenue 5,807,000 70,355,000 12,965,000
Operating lease liabilities (59,188,000) (49,147,000) (48,588,000)
Other assets and liabilities (17,545,000) (27,554,000) (14,322,000)
Net cash provided by operating activities-continuing operations 205,684,000 164,002,000 168,760,000
Net cash (used in) provided by operating activities-discontinued operations (2,776,000) (153,401,000) 23,439,000
Net cash provided by operating activities 202,908,000 10,601,000 192,199,000
Investing activities:      
Capital expenditures (37,008,000) (31,054,000) (39,881,000)
Proceeds from sales of marketable securities 7,635,000 3,447,000 2,721,000
Purchases of marketable securities (1,508,000) (3,624,000) (10,745,000)
Proceeds from note receivable related to property sold 46,800,000 0 0
Payment for purchase of business, net of cash and restricted cash acquired 0 (1,488,054,000) 0
Net cash provided by (used in) investing activities-continuing operations 15,919,000 (1,509,285,000) (47,905,000)
Net cash used in investing activities-discontinued operations 0 (3,287,000) (8,783,000)
Proceeds from sale of business, net of cash transferred 0 960,768,000 0
Payment for working capital adjustment for sale of business (3,174,000) 0 0
Net cash provided by (used in) investing activities 12,745,000 (551,804,000) (56,688,000)
Financing activities:      
Proceeds from exercise of stock options 2,625,000 8,879,000 1,457,000
Employee taxes paid on withholding shares (4,592,000) (2,834,000) (4,206,000)
Proceeds from stock issued under Colleague Stock Purchase Plan 608,000 535,000 262,000
Repurchases of common stock for treasury (123,133,000) (120,000,000) (100,000,000)
Payment on equity forward contract (13,162,000) (30,000,000) 0
Proceeds from long-term debt 0 850,000,000 800,000,000
Repayments of long-term debt (150,861,000) (1,079,713,000) (3,000,000)
Payment of debt discount and issuance costs 0 (49,553,000) (18,047,000)
Payment for purchase of redeemable noncontrolling interest of subsidiary 0 (1,790,000) 0
Net cash (used in) provided by financing activities (288,515,000) (424,476,000) 676,466,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash 0 0 534,000
Net (decrease) increase in cash, cash equivalents and restricted cash (72,862,000) (965,679,000) 812,511,000
Cash, cash equivalents and restricted cash at beginning of period 347,937,000 1,313,616,000 501,105,000
Cash, cash equivalents and restricted cash at end of period 275,075,000 347,937,000 1,313,616,000
Less: cash, cash equivalents and restricted cash of discontinued operations at end of period 0 0 18,236,000
Cash, cash equivalents and restricted cash of continuing operations at end of period 275,075,000 347,937,000 1,295,380,000
Supplemental cash flow disclosure:      
Interest paid 53,126,000 107,093,000 14,429,000
Income taxes paid, net 12,312,000 94,355,000 26,431,000
Non-cash investing and financing activities:      
Accrued capital expenditures 8,203,000 4,321,000 3,380,000
Accrued liability for repurchases of common stock 2,995,000 0 0
Accrued excise tax on share repurchases 1,126,000 0 0
Settlement of financing liability with assets 38,606,000 0 0
Decrease in redemption value of redeemable noncontrolling interest put option 0 0 (628,000)
DeVry University      
Investing activities:      
Proceeds from note receivable related to property sold $ 0 $ 10,000,000 $ 0